Flu, Human: Clinical Trials

8 trials for Flu, Human, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 1 unknown. 3 Not applicable, 3 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 3
Phase 33Completed 3
Phase 11Completed 1

Follow Flu, Human: new trials by email Literature Review of Flu, Human trials Research Report on Flu, Human

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effectiveness of a Nasal Spray on Viral Respiratory Infections
Nasal Spray HSV Treatment - Acute Respiratory Tract Infection, Flu, Human
Not applicableCompletedCEN Biotech762024-01-262025-08-07
A Study to Prove Non-inferior Immunogenicity of Grippol Quadrivalent Compared to Grippol Plus
Grippol Quadrivalent, Grippol Plus - Influenza, Influenza A
Phase 3CompletedNPO Petrovax8242022-09-212024-04-26
Tolerability, Safety and Immunogenicity Trial of the Flu-M® Inactivated Vaccine in Volunteers Aged 18 to 60 Years
Flu-M [inactivated split influenza vaccine] without preservative, Flu-M [inactivated split influenza vaccine] with preservative - Influenza, Flu, Human
Phase 3CompletedSt. Petersburg Research Institute of Vaccines and Sera6542020-12-072022-04-05
Persuasion in Medicine: Experimental Evidence on Sender and Signal Effects
Video about safety and effectiveness of adult seasonal flu vaccination - Flu, Human, Influenza, Human
Not applicableCompletedHarvard University32452019-12-202021-06-29
Factors Influencing Flu Vaccination in Primary Health Care
Brief educational intervention - Flu, Human
Not applicableCompletedAgrupamento de Centros de Saúde de Dão Lafões1972019-10-142020-06-01
Volatiles in Breath and Headspace Analysis - Diagnostic Markers
VOC detection in breath and in skin headspace, Breath sampling, Upper endoscopy with biopsies - Tuberculosis, Gastric Cancer
UnknownUniversity of Latvia30002017-07-242018-08-21
Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Immunosuppressive Conditions *aH5N1:Monovalent H5N1 Influenza Vaccine
Novartis Investigational H5N1 vaccine, Novartis Seasonal Influenza Vaccine - Influenza, Human, Flu, Human
Phase 3CompletedSeqirus5392014-04-012016-05-09
Study of the Safety, Tolerability and Immunogenicity of an Intranasal Influenza Vaccine Administered to Healthy Adults
DCB07010, HA antigens - Flu, Human
Phase 1CompletedAdvagene Biopharma Co. Ltd.362012-11-282020-01-07

Narrower conditions

Influenza, Human (8)  ·  COVID-19 (2)  ·  Colorectal Neoplasms (1)  ·  Common Cold (1)  ·  Gastritis, Atrophic (1)  ·  Gastrointestinal Neoplasms (1)  ·  Inflammatory Bowel Diseases (1)  ·  Influenza in Birds (1)  ·  Liver Cirrhosis (1)  ·  Liver Neoplasms (1)  ·  Orthomyxoviridae Infections (1)  ·  Pancreatic Neoplasms (1)  ·  Pancreatitis, Chronic (1)  ·  Peptic Ulcer (1)  ·  Stomach Neoplasms (1)

Broader conditions

Infections (8)  ·  RNA Virus Infections (8)  ·  Respiratory Tract Diseases (8)  ·  Respiratory Tract Infections (8)  ·  Virus Diseases (8)  ·  Orthomyxoviridae Infections (7)  ·  Coronaviridae Infections (2)  ·  Coronavirus Infections (2)  ·  Lung Diseases (2)  ·  Nidovirales Infections (2)  ·  Pneumonia (2)  ·  Pneumonia, Viral (2)  ·  Actinomycetales Infections (1)  ·  Animal Diseases (1)  ·  Bacterial Infections (1)

Interventions

Biopsy (1)  ·  Colonoscopy (1)  ·  Gastroscopy (1)  ·  Grippol (1)

Sponsors

Advagene Biopharma Co. Ltd. (1)  ·  Agrupamento de Centros de Saúde de Dão Lafões (1)  ·  CEN Biotech (1)  ·  Harvard University (1)  ·  NPO Petrovax (1)  ·  Seqirus (1)  ·  St. Petersburg Research Institute of Vaccines and Sera (1)  ·  University of Latvia (1)

Countries

Russia (2)  ·  Australia (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Latvia (1)  ·  Portugal (1)  ·  Taiwan (1)  ·  United States (1)

Top investigators

Lelde Lauka, MD (1)  ·  Shaun-Chwen Chang, Ph.D. (1)

Results publications

PMID 30837170

NIH funding

2017 (1)